Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.24% is 78% below its 5-year average of 5.56%, near the low end of its 5-year range (0.76%–11.50%).
As of the fiscal period ended Wednesday, December 31, 2025. 77.61% below its 12-month average of 5.56%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2025-12-31): 1.24%.
DEBT TO ASSETS RATIO
1.24%
DEBT TO ASSETS RATIO AVG TTM
5.56%
DEBT TO ASSETS RATIO AVG 3Y
6.41%
DEBT TO ASSETS RATIO AVG 5Y
5.56%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-77.61%
CURRENT VS 3Y AVG
-80.59%
CURRENT VS 5Y AVG
-77.63%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+1282.56%
vs the sector median at left
Mobile-health Network Solutions Class A Ordinary Shares
Market Cap
$30054.00
Debt to Assets Ratio
1.24%
TTM Avg
5.56%
3Y Avg
6.41%
5Y Avg
5.56%
Market Cap
$6235.00
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$71053.00
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$95475.00
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$106970.00
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$378849.00
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR) | $30054.00 | 1.24% | 5.56% | 6.41% | 5.56% |
| Zhongchao Inc. (ZCMD)vs › | $30389.00 | 0.00% | N/A | N/A | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $6235.00 | 0.15% | N/A | N/A | N/A |
| Akanda Corp. (AKAN)vs › | $61172.00 | 2.89% | N/A | N/A | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $71053.00 | 0.00% | N/A | N/A | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | 0.00% | N/A | N/A | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $106970.00 | 0.33% | N/A | N/A | N/A |
| SciSparc Ltd. (SPRC)vs › | $252756.00 | 0.05% | N/A | N/A | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $378849.00 | 0.05% | N/A | N/A | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $385197.00 | 0.18% | N/A | N/A | N/A |
Debt/Assets
1.2%
Debt/Equity
0.01
Current Ratio
4.22
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2025-12-31 | 1.24% |
| 2025-06-30 | 6.98% |
| 2024-12-31 | 8.44% |
| 2024-06-30 | 5.17% |
| 2023-12-31 | 9.84% |
| 2023-06-30 | 11.50% |
| 2022-12-31 | 1.68% |
| 2022-06-30 | 0.76% |
| 2021-12-30 | 1.23% |
| 2021-06-30 | 8.76% |
